Taken together, our study demonstrates that miR-141-5p plays an important role in the activation of K562 cells in vitro and may act as a tumor suppressor via targeting RAB32 in the development of CML. The gene discussed is RAB32; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.